Nasdaq · Common stock
Cabaletta Bio (CABA)
$1.35 −$0.12 (−8.16%)
- Day’s range
- $1.32–$1.48
- Volume
- 6.2M
CABA price history
CABA closed at $1.35 on Oct. 26, 2026. Over the past year, its daily close ranged from $1.35 on Oct. 26, 2026 to $4.15 on May 5, 2026.
Data table: CABA daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $1.35 |
| Oct. 23, 2026 | $1.47 |
| Oct. 22, 2026 | $1.52 |
| Oct. 21, 2026 | $1.54 |
| Oct. 20, 2026 | $1.61 |
| Oct. 19, 2026 | $1.48 |
| Oct. 16, 2026 | $1.41 |
| Oct. 15, 2026 | $1.55 |
| Oct. 14, 2026 | $1.62 |
| Oct. 13, 2026 | $1.69 |
| Oct. 12, 2026 | $1.79 |
| Oct. 9, 2026 | $1.93 |
| Oct. 8, 2026 | $1.95 |
| Oct. 7, 2026 | $1.97 |
| Oct. 6, 2026 | $2.02 |
| Oct. 5, 2026 | $2.08 |
| Oct. 2, 2026 | $2.00 |
| Oct. 1, 2026 | $1.89 |
| Sept. 30, 2026 | $1.92 |
| Sept. 29, 2026 | $1.98 |
| Sept. 28, 2026 | $2.00 |
| Sept. 25, 2026 | $2.07 |
| Sept. 24, 2026 | $2.15 |
| Sept. 23, 2026 | $2.22 |
| Sept. 22, 2026 | $2.50 |
| Sept. 21, 2026 | $2.46 |
| Sept. 18, 2026 | $2.55 |
| Sept. 17, 2026 | $2.58 |
| Sept. 16, 2026 | $2.49 |
| Sept. 15, 2026 | $2.60 |
| Sept. 14, 2026 | $2.91 |
| Sept. 11, 2026 | $2.73 |
| Sept. 10, 2026 | $2.74 |
| Sept. 9, 2026 | $2.91 |
| Sept. 8, 2026 | $3.27 |
| Sept. 4, 2026 | $3.47 |
| Sept. 3, 2026 | $3.48 |
| Sept. 2, 2026 | $3.57 |
| Sept. 1, 2026 | $3.30 |
| Aug. 31, 2026 | $3.11 |
| Aug. 28, 2026 | $3.12 |
| Aug. 27, 2026 | $3.38 |
| Aug. 26, 2026 | $3.25 |
| Aug. 25, 2026 | $3.22 |
| Aug. 24, 2026 | $3.10 |
| Aug. 21, 2026 | $3.13 |
| Aug. 20, 2026 | $3.19 |
| Aug. 19, 2026 | $3.10 |
| Aug. 18, 2026 | $2.91 |
| Aug. 17, 2026 | $2.89 |
| Aug. 14, 2026 | $2.75 |
| Aug. 13, 2026 | $2.71 |
| Aug. 12, 2026 | $2.85 |
| Aug. 11, 2026 | $2.79 |
| Aug. 10, 2026 | $2.80 |
| Aug. 7, 2026 | $2.79 |
| Aug. 6, 2026 | $2.76 |
| Aug. 5, 2026 | $2.71 |
| Aug. 4, 2026 | $2.77 |
| Aug. 3, 2026 | $2.69 |
| July 31, 2026 | $2.68 |
| July 30, 2026 | $2.72 |
| July 29, 2026 | $2.62 |
| July 28, 2026 | $2.73 |
| July 27, 2026 | $2.72 |
| July 24, 2026 | $2.69 |
| July 23, 2026 | $2.72 |
| July 22, 2026 | $2.75 |
| July 21, 2026 | $2.82 |
| July 20, 2026 | $2.75 |
| July 17, 2026 | $2.83 |
| July 16, 2026 | $2.67 |
| July 15, 2026 | $2.77 |
| July 14, 2026 | $2.67 |
| July 13, 2026 | $2.77 |
| July 10, 2026 | $2.98 |
| July 9, 2026 | $3.12 |
| July 8, 2026 | $3.13 |
| July 7, 2026 | $3.10 |
| July 6, 2026 | $3.01 |
| July 2, 2026 | $3.19 |
| July 1, 2026 | $2.99 |
| June 30, 2026 | $3.11 |
| June 29, 2026 | $3.11 |
| June 26, 2026 | $3.04 |
| June 25, 2026 | $2.92 |
| June 24, 2026 | $3.03 |
| June 23, 2026 | $3.02 |
| June 22, 2026 | $3.01 |
| June 18, 2026 | $2.84 |
| June 17, 2026 | $2.84 |
| June 16, 2026 | $2.80 |
| June 15, 2026 | $3.01 |
| June 12, 2026 | $3.01 |
| June 11, 2026 | $3.01 |
| June 10, 2026 | $3.04 |
| June 9, 2026 | $3.22 |
| June 8, 2026 | $3.20 |
| June 5, 2026 | $3.25 |
| June 4, 2026 | $3.51 |
| June 3, 2026 | $3.58 |
| June 2, 2026 | $3.68 |
| June 1, 2026 | $3.67 |
| May 29, 2026 | $3.78 |
| May 28, 2026 | $3.77 |
| May 27, 2026 | $3.83 |
| May 26, 2026 | $3.72 |
| May 22, 2026 | $3.65 |
| May 21, 2026 | $3.69 |
| May 20, 2026 | $3.44 |
| May 19, 2026 | $3.27 |
| May 18, 2026 | $3.29 |
| May 15, 2026 | $3.31 |
| May 14, 2026 | $3.61 |
| May 13, 2026 | $3.59 |
| May 12, 2026 | $3.63 |
| May 11, 2026 | $3.82 |
| May 8, 2026 | $3.88 |
| May 7, 2026 | $4.00 |
| May 6, 2026 | $3.73 |
| May 5, 2026 | $4.15 |
| May 4, 2026 | $3.83 |
| May 1, 2026 | $2.94 |
| April 30, 2026 | $2.99 |
| April 29, 2026 | $2.78 |
| April 28, 2026 | $2.86 |
| April 27, 2026 | $2.91 |
| April 24, 2026 | $2.95 |
| April 23, 2026 | $3.05 |
| April 22, 2026 | $3.17 |
| April 21, 2026 | $3.13 |
| April 20, 2026 | $3.31 |
| April 17, 2026 | $3.44 |
| April 16, 2026 | $3.52 |
| April 15, 2026 | $3.40 |
| April 14, 2026 | $3.26 |
| April 13, 2026 | $3.20 |
| April 10, 2026 | $3.13 |
| April 9, 2026 | $3.17 |
| April 8, 2026 | $3.09 |
| April 7, 2026 | $3.07 |
| April 6, 2026 | $3.01 |
| April 2, 2026 | $2.96 |
| April 1, 2026 | $2.68 |
| March 31, 2026 | $2.69 |
| March 30, 2026 | $2.47 |
| March 27, 2026 | $2.68 |
| March 26, 2026 | $2.82 |
| March 25, 2026 | $2.78 |
| March 24, 2026 | $2.67 |
| March 23, 2026 | $2.82 |
| March 20, 2026 | $2.94 |
| March 19, 2026 | $3.04 |
| March 18, 2026 | $2.97 |
| March 17, 2026 | $3.10 |
| March 16, 2026 | $3.20 |
| March 13, 2026 | $3.06 |
| March 12, 2026 | $3.19 |
| March 11, 2026 | $3.27 |
| March 10, 2026 | $3.32 |
| March 9, 2026 | $3.27 |
| March 6, 2026 | $3.17 |
| March 5, 2026 | $3.18 |
| March 4, 2026 | $3.43 |
| March 3, 2026 | $3.25 |
| March 2, 2026 | $3.30 |
| Feb. 27, 2026 | $3.32 |
| Feb. 26, 2026 | $3.48 |
| Feb. 25, 2026 | $3.49 |
| Feb. 24, 2026 | $3.29 |
| Feb. 23, 2026 | $2.90 |
| Feb. 20, 2026 | $2.91 |
| Feb. 19, 2026 | $3.14 |
| Feb. 18, 2026 | $3.13 |
| Feb. 17, 2026 | $2.96 |
| Feb. 13, 2026 | $2.80 |
| Feb. 12, 2026 | $2.85 |
| Feb. 11, 2026 | $2.57 |
| Feb. 10, 2026 | $2.60 |
| Feb. 9, 2026 | $2.44 |
| Feb. 6, 2026 | $2.51 |
| Feb. 5, 2026 | $2.33 |
| Feb. 4, 2026 | $2.51 |
| Feb. 3, 2026 | $2.59 |
| Feb. 2, 2026 | $2.50 |
| Jan. 30, 2026 | $2.57 |
| Jan. 29, 2026 | $2.75 |
| Jan. 28, 2026 | $2.85 |
| Jan. 27, 2026 | $3.02 |
| Jan. 26, 2026 | $2.95 |
| Jan. 23, 2026 | $3.18 |
| Jan. 22, 2026 | $2.94 |
| Jan. 21, 2026 | $2.34 |
| Jan. 20, 2026 | $2.19 |
| Jan. 16, 2026 | $2.20 |
| Jan. 15, 2026 | $2.08 |
| Jan. 14, 2026 | $2.15 |
| Jan. 13, 2026 | $2.15 |
| Jan. 12, 2026 | $2.21 |
| Jan. 9, 2026 | $2.10 |
| Jan. 8, 2026 | $2.17 |
| Jan. 7, 2026 | $2.14 |
| Jan. 6, 2026 | $2.04 |
| Jan. 5, 2026 | $2.20 |
| Jan. 2, 2026 | $2.21 |
| Dec. 31, 2025 | $2.19 |
| Dec. 30, 2025 | $2.15 |
| Dec. 29, 2025 | $2.28 |
| Dec. 26, 2025 | $2.19 |
| Dec. 24, 2025 | $2.19 |
| Dec. 23, 2025 | $2.18 |
| Dec. 22, 2025 | $2.39 |
| Dec. 19, 2025 | $2.39 |
| Dec. 18, 2025 | $2.41 |
| Dec. 17, 2025 | $2.33 |
| Dec. 16, 2025 | $2.39 |
| Dec. 15, 2025 | $2.39 |
| Dec. 12, 2025 | $2.36 |
| Dec. 11, 2025 | $2.36 |
| Dec. 10, 2025 | $2.42 |
| Dec. 9, 2025 | $2.50 |
| Dec. 8, 2025 | $2.48 |
| Dec. 5, 2025 | $2.55 |
| Dec. 4, 2025 | $2.56 |
| Dec. 3, 2025 | $2.50 |
| Dec. 2, 2025 | $2.34 |
| Dec. 1, 2025 | $2.43 |
| Nov. 28, 2025 | $2.57 |
| Nov. 26, 2025 | $2.37 |
| Nov. 25, 2025 | $2.20 |
| Nov. 24, 2025 | $2.30 |
| Nov. 21, 2025 | $2.08 |
| Nov. 20, 2025 | $2.15 |
| Nov. 19, 2025 | $2.24 |
| Nov. 18, 2025 | $2.34 |
| Nov. 17, 2025 | $2.39 |
| Nov. 14, 2025 | $2.31 |
| Nov. 13, 2025 | $2.34 |
| Nov. 12, 2025 | $2.45 |
| Nov. 11, 2025 | $2.47 |
| Nov. 10, 2025 | $2.43 |
| Nov. 7, 2025 | $2.55 |
| Nov. 6, 2025 | $2.48 |
| Nov. 5, 2025 | $2.61 |
| Nov. 4, 2025 | $2.70 |
| Nov. 3, 2025 | $3.01 |
| Oct. 31, 2025 | $3.61 |
| Oct. 30, 2025 | $2.47 |
| Oct. 29, 2025 | $2.50 |
| Oct. 28, 2025 | $2.74 |
| Oct. 27, 2025 | $2.79 |
Key figures
- 52-week range
- $1.35–$4.15Low Oct. 26, 2026; high May 5, 2026
- Average daily volume
- 5.0MPast 3 months
- Market value
- $228.9M
- Dividend yield
- —
- From 52-week high
- −67.47%
Price change
- 1 month
- −34.78%
- 3 months
- −49.81%
- Year to date
- −38.36%
- 1 year
- −45.34%
$1,000 a year ago
$1,000 put into CABA at the close on Oct. 24, 2025 would be worth $547.
Price only, dividends not included.
What Wall Street says about CABA
In the past 90 days, Wall Street firms published 2 rating or price-target actions on CABA: 1 reiterated rating and 1 lowered price target.
| Action | Rating | |||
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterates | Buy | $16 | |
| Wells Fargo | Cuts target | Equal-weight | $4 to $3 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Cabaletta Bio, Inc. Common Stock
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
- Headquarters
- Philadelphia, Pa.
- Employees
- 158
- Listed
- Oct. 25, 2019
- Sector
- Health care
- Industry
- Biological products, (no diagnostic substances)
In WallStreetDigest editions
No WallStreetDigest article about CABA is on the site yet.